EQT to acquire a majority stake in Adalvo.

EQT Partners, a global private equity firm, agreed to acquire a majority stake in Adalvo, a B2B dossier developer. Financial terms were not disclosed. "EQT is deeply impressed by Adalvo's competitive position in dossier development, with an agile and scalable model for development and partnerships with leading pharmaceutical companies globally. We look forward to joining forces with the entrepreneurial and highly respected management team, led by CEO Anil Okay, and to investing in the next chapter of continued growth. Looking ahead, we are committed to supporting Adalvo and its employees in its pivotal role to provide access to affordable healthcare to patients around the world. We are impressed by what Adalvo has achieved under Róbert Wessman's ownership, and are delighted that he will also be part of the next phase of the journey as a minority shareholder," Matteo Thun, EQT Partner.